Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 1600 1621 1624 1626 3646
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18263059 | IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION INCLUDING BENZENE DERIVATIVE AS IMMUNOSUPPRESSANT | Final Rejection | PROVIBIO CO., LTD. |
| 18251101 | CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR | Non-Final OA | LG CHEM, LTD. |
| 18017732 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED REACTION COMPOSITION | Final Rejection | LG CHEM, LTD. |
| 18283264 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 18262429 | METHOD FOR THE CONTROL OR SUPPRESSION OF PHYTOPATHOGENIC BACTERIA | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 17906580 | FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE | Non-Final OA | ELI LILLY AND COMPANY |
| 18228422 | SELECTIVE BRD4-DEGRADER MOLECULES | Final Rejection | Regents of the University of Minnesota |
| 18022962 | MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF | Non-Final OA | Massachusetts Institute of Technology |
| 18176877 | INHIBITION OF URACIL DNA GLYCOSYLASE IN THE OPEN CONFORMATION | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18546322 | RADIOLABELED COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | The Research Foundation for the State University of New York |
| 17597166 | IRAK DEGRADERS AND USES THEREOF | Final Rejection | Kymera Therapeutics, Inc. |
| 18683361 | IMPROVED METHODS FOR PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | Non-Final OA | IMMUNOGEN, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy